Med BioGene Inc
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was involved in the life science business with a focus on the commercialization of prognostic genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. Many Bright Ideas Technologies Inc. is headquartered in Vancouver, Canad… Read more
Med BioGene Inc (MBGNF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.066x
Based on the latest financial reports, Med BioGene Inc (MBGNF) has a cash flow conversion efficiency ratio of 0.066x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-14.04K) by net assets ($-211.92K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Med BioGene Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Med BioGene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Med BioGene Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Med BioGene Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Neuberger Berman IMF Inc
NYSE MKT:NBH
|
-0.035x |
|
Aditxt Inc.
NASDAQ:ADTX
|
0.265x |
|
ENSPF
PINK:ENSPF
|
N/A |
|
BlackRock Long-Term Municipal Advantage Trust
NYSE:BTA
|
0.021x |
|
PMFAX
NMFQS:PMFAX
|
N/A |
|
Seoyonehwa
KQ:200880
|
N/A |
|
Porto Aviation Group S.p.A.
F:M2N
|
N/A |
|
A.G.Barr PLC
LSE:BAG
|
0.048x |
Annual Cash Flow Conversion Efficiency for Med BioGene Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Med BioGene Inc from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-168.53K | $-12.40K | 0.074x | +417.33% |
| 2023-12-31 | $-126.98K | $2.94K | -0.023x | -118.45% |
| 2022-12-31 | $-66.23K | $-8.32K | 0.126x | -92.97% |
| 2021-12-31 | $-81.22K | $-145.12K | 1.787x | +336.43% |
| 2020-12-31 | $-96.34K | $72.80K | -0.756x | -118.59% |
| 2019-12-31 | $-37.27K | $-151.46K | 4.064x | +6453.20% |
| 2018-12-31 | $-133.82K | $-8.30K | 0.062x | -86.65% |
| 2017-12-31 | $-89.27K | $-41.45K | 0.464x | -80.15% |
| 2016-12-31 | $-4.77K | $-11.16K | 2.340x | +9.86% |
| 2015-12-31 | $-60.22K | $-128.26K | 2.130x | -62.39% |
| 2014-12-31 | $-38.30K | $-216.84K | 5.662x | +260.11% |
| 2013-12-31 | $112.62K | $-398.29K | -3.536x | -216.20% |
| 2012-12-31 | $294.65K | $-329.55K | -1.118x | -346.39% |
| 2011-12-31 | $556.45K | $252.59K | 0.454x | -62.29% |
| 2010-12-31 | $-1.49 Million | $-1.80 Million | 1.204x | +227.64% |
| 2009-12-31 | $1.25 Million | $-1.18 Million | -0.943x | +54.68% |
| 2008-12-31 | $850.68K | $-1.77 Million | -2.081x | -65.98% |
| 2007-12-31 | $1.62 Million | $-2.03 Million | -1.254x | +60.85% |
| 2006-12-31 | $245.40K | $-785.84K | -3.202x | -767.14% |
| 2005-12-31 | $-659.88K | $-316.74K | 0.480x | -7.54% |
| 2004-12-31 | $-344.44K | $-178.82K | 0.519x | -- |